Perceptive Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $50.7M | Buy |
|
|||||
2025
Q1 | $27.9M | Buy |
|
|||||
2024
Q4 | $25.6M | Buy |
|
|||||
2024
Q3 | $6.89M | Buy |
|
|||||
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $852K | Sell |
|
|||||
2023
Q4 | $27.5M | Sell |
|
|||||
2023
Q3 | $49.2M | Sell |
|
|||||
2023
Q2 | $105M | Sell |
|
|||||
2023
Q1 | $177M | Sell |
|
|||||
2022
Q4 | $225M | Buy |
|
|||||
2022
Q3 | $154M | Buy |
|
|||||
2022
Q2 | $68.2M | Buy |
|
|||||
2022
Q1 | $18.9M | Buy |
|